EA201301150A1 - Новые пиперидинилмонокарбоновые кислоты в качестве агонистов s1p1 рецепторов - Google Patents

Новые пиперидинилмонокарбоновые кислоты в качестве агонистов s1p1 рецепторов

Info

Publication number
EA201301150A1
EA201301150A1 EA201301150A EA201301150A EA201301150A1 EA 201301150 A1 EA201301150 A1 EA 201301150A1 EA 201301150 A EA201301150 A EA 201301150A EA 201301150 A EA201301150 A EA 201301150A EA 201301150 A1 EA201301150 A1 EA 201301150A1
Authority
EA
Eurasian Patent Office
Prior art keywords
agonists
receptors
new
new piperidinyl
monocarbon acids
Prior art date
Application number
EA201301150A
Other languages
English (en)
Other versions
EA023638B1 (ru
Inventor
Марк Капе
Изабэль Берреби-Бертран
Филипп Робер
Жан-Шарль Шварц
Жанн-Мари Лёкомт
Раджаманнар Тхеннати
Ранджан Кумар Пал
Бисваджит Саманта
Мутхукумаран Натараджан Пиллай
Джапан Натинкумар Десай
Диджикса Чандубхай Рана
Каушик Дханджубхай Праджапати
Сандееп Панкаджбхай Патхак
Бхавеш М. Панчал
Джайрай Д. Арадхие
Original Assignee
Биопроже
Сан Фарма Эдванст Рисерч Компани Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биопроже, Сан Фарма Эдванст Рисерч Компани Лтд. filed Critical Биопроже
Publication of EA201301150A1 publication Critical patent/EA201301150A1/ru
Publication of EA023638B1 publication Critical patent/EA023638B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)

Abstract

Настоящее изобретение относится к новым соединениям, действующим в качестве агонистов S1P (сфингозин-1-фосфат) рецепторов, к композициям, содержащим эти соединения, к применениям этих соединений в медицине и к способу их получения.
EA201301150A 2011-04-12 2012-04-10 Производные 1-{4-(5-арил-[1,2,4]-оксадиазол-3-ил)бензил}пиперидин-4-илкарбоновой кислоты в качестве агонистов s1p1 рецепторов EA023638B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11305433A EP2511275A1 (en) 2011-04-12 2011-04-12 Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
PCT/EP2012/056470 WO2012140020A1 (en) 2011-04-12 2012-04-10 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists

Publications (2)

Publication Number Publication Date
EA201301150A1 true EA201301150A1 (ru) 2014-03-31
EA023638B1 EA023638B1 (ru) 2016-06-30

Family

ID=43984071

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301150A EA023638B1 (ru) 2011-04-12 2012-04-10 Производные 1-{4-(5-арил-[1,2,4]-оксадиазол-3-ил)бензил}пиперидин-4-илкарбоновой кислоты в качестве агонистов s1p1 рецепторов

Country Status (24)

Country Link
US (1) US9266867B2 (ru)
EP (2) EP2511275A1 (ru)
JP (1) JP6050315B2 (ru)
KR (1) KR101854152B1 (ru)
CN (1) CN103619838B (ru)
AU (1) AU2012241981B2 (ru)
BR (1) BR112013026434B1 (ru)
CA (1) CA2833180C (ru)
CO (1) CO6801772A2 (ru)
DK (1) DK2697219T3 (ru)
EA (1) EA023638B1 (ru)
EC (1) ECSP13012983A (ru)
ES (1) ES2544616T3 (ru)
HU (1) HUE025443T2 (ru)
IL (1) IL228844A (ru)
MA (1) MA35305B1 (ru)
MX (1) MX342926B (ru)
PL (1) PL2697219T3 (ru)
PT (1) PT2697219E (ru)
SG (1) SG194183A1 (ru)
TN (1) TN2013000425A1 (ru)
UA (1) UA110822C2 (ru)
WO (1) WO2012140020A1 (ru)
ZA (1) ZA201307820B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY196990A (en) 2016-07-13 2023-05-17 Leo Pharma As Heteroaromatic modulators of the retinoid-related orphan receptor gamma
CN111807954B (zh) * 2019-04-10 2024-04-05 广东东阳光药业股份有限公司 一种辛波莫德中间体的制备方法
CN113332435B (zh) * 2021-06-18 2022-10-18 广州中医药大学(广州中医药研究院) 鞘氨醇-1-磷酸4受体激动剂及其与真武汤联合在制备治疗慢性肾小球肾炎药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003207567B2 (en) * 2002-01-18 2008-01-24 Merck Sharp & Dohme Corp. Edg receptor agonists
WO2003105771A2 (en) 2002-06-17 2003-12-24 Merck & Co., Inc. 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
UA91129C2 (ru) 2006-05-09 2010-06-25 Пфайзер Продактс Инк. Производные циклоалкиламинокислот и фармацевтическая композиция, которая их содержит
US7834039B2 (en) * 2006-12-15 2010-11-16 Abbott Laboratories Oxadiazole compounds
EP2014653A1 (en) 2007-06-15 2009-01-14 Bioprojet Novel dicarboxylic acid derivatives as S1P1 receptor agonists
AU2008306885B2 (en) * 2007-10-04 2013-12-05 Merck Serono S.A. Oxadiazole derivatives
GB0725102D0 (en) * 2007-12-21 2008-01-30 Glaxo Group Ltd Compounds
US8193378B2 (en) * 2008-12-05 2012-06-05 Astellas Pharma Inc. 2H-chromene compound and derivative thereof
EP2305660A1 (en) * 2009-09-25 2011-04-06 Almirall, S.A. New thiadiazole derivatives
EP2366702A1 (en) * 2010-03-18 2011-09-21 Almirall, S.A. New oxadiazole derivatives
CN106278999B (zh) * 2011-02-07 2019-10-25 比奥根Ma公司 S1p调节剂

Also Published As

Publication number Publication date
CA2833180A1 (en) 2012-10-18
SG194183A1 (en) 2013-12-30
HUE025443T2 (en) 2016-04-28
DK2697219T3 (en) 2015-06-15
EP2697219B1 (en) 2015-03-04
JP6050315B2 (ja) 2016-12-21
TN2013000425A1 (en) 2015-03-30
CN103619838A (zh) 2014-03-05
AU2012241981B2 (en) 2016-12-15
MX2013011984A (es) 2014-06-23
CA2833180C (en) 2021-09-28
IL228844A (en) 2016-11-30
JP2014510770A (ja) 2014-05-01
IL228844A0 (en) 2013-12-31
US20140099316A1 (en) 2014-04-10
KR101854152B1 (ko) 2018-05-04
ECSP13012983A (es) 2014-05-31
WO2012140020A1 (en) 2012-10-18
PT2697219E (pt) 2015-07-09
BR112013026434A2 (pt) 2016-12-20
MA35305B1 (fr) 2014-08-01
AU2012241981A1 (en) 2013-10-31
ZA201307820B (en) 2014-11-26
CN103619838B (zh) 2016-08-24
ES2544616T3 (es) 2015-09-02
UA110822C2 (uk) 2016-02-25
US9266867B2 (en) 2016-02-23
NZ617500A (en) 2016-03-31
EP2697219A1 (en) 2014-02-19
BR112013026434B1 (pt) 2021-12-28
CO6801772A2 (es) 2013-11-29
PL2697219T3 (pl) 2015-10-30
EA023638B1 (ru) 2016-06-30
KR20140041486A (ko) 2014-04-04
MX342926B (es) 2016-10-19
EP2511275A1 (en) 2012-10-17

Similar Documents

Publication Publication Date Title
UY33317A (es) Nuevos derivados de pirazol
EA201501122A8 (ru) Новые агонисты соматостатиновых рецепторов подтипа 4 (sstr4)
EA201200239A1 (ru) Бициклические арильные аналоги сфингозин 1-фосфата
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201690312A1 (ru) Улучшенная липидная композиция
EA201491362A1 (ru) Анестезирующие соединения и способы их применения
GEP20227397B (en) Inhibitors of influenza viruses replication
MX2015005858A (es) Moduladores del receptor acoplado a proteina g (gpr40) de dihidropirazol.
ECSP10010169A (es) Composiciones que comprenden moduladores del receptor de fosfato de esfingosina-1 (s1p)
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
EA201000024A1 (ru) Новые производные дикарбоновых кислот в качестве агонистов рецептора s1p1
MX358499B (es) Moduladores de dihidropirazol del receptor acoplado a la proteína g (gpr40).
EA201590887A1 (ru) Композиция
EA201391481A1 (ru) Аналоги эпоксиэйкозатриеновой кислоты и способы их получения и использования
MX2015005720A (es) Moduladores de dihidropirazol de receptor acoplado a la proteina g (gpr40).
EA200971140A1 (ru) Триарильные соединения и композиции, их содержащие
EA201301181A1 (ru) Триазолопиридины
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
EA201490756A1 (ru) Разагилина цитрамид
GEP20135862B (en) Novel benzothiadiazepine compounds, method of their preparation, and pharmaceutical compositions containing thereof
EA201391056A1 (ru) Гетероарильные соединения в качестве лигандов 5-htрецептора
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201391124A1 (ru) Новые бензодиоксолпиперазиновые соединения
MX2013000009A (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
WO2012071212A3 (en) Novel phosphonic acids as s1p receptor modulators

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM